NASDAQ:TRAX First Tracks Biotherapeutics Q2 2026 Earnings Results & Report $36.04 +1.91 (+5.60%) Closing price 04:00 PM EasternExtended Trading$35.66 -0.38 (-1.05%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. First Tracks Biotherapeutics missed analyst earnings expectations in its Q2 2026 results, released August 12, 2026. The company reported EPS of -$0.95 versus the -$0.74 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 12, 2026TimeAfter Market ClosesConference Call4:00 PM ET First Tracks Biotherapeutics EPS ResultsActual EPS-$0.95Consensus EPS -$0.74Beat/MissMissed by -$0.21One Year Ago EPSN/AFirst Tracks Biotherapeutics Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) First Tracks Biotherapeutics Q2 2026 Earnings FAQ Did First Tracks Biotherapeutics beat earnings estimates for Q2 2026? First Tracks Biotherapeutics (NASDAQ:TRAX) reported earnings of -$0.95 per share for Q2 2026, missing the consensus estimate of -$0.74. The report was announced on Wednesday, August 12, 2026. First Tracks Biotherapeutics Earnings HeadlinesFirst Tracks Biotherapeutics announces $200M private placementOctober 15 at 12:17 PM | msn.comFirst Tracks Biotherapeutics Announces $200 Million Private PlacementOctober 15 at 8:00 AM | globenewswire.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.October 15 at 1:00 AM | Porter & Company (Ad)Analysts Offer Insights on NA Companies: First Tracks Biotherapeutics Inc (TRAX), Klarna Group Plc (KLAR) and Factset Research (FDS)October 14 at 11:14 AM | theglobeandmail.comFirst Tracks Biotherapeutics: Teva Validated The Pathway, ANB033 May Own The ReceptorOctober 14 at 8:31 AM | seekingalpha.comFirst Tracks Biotherapeutics (TRAX) Stock Looks Rich Following Phase 1b Celiac DataOctober 13 at 12:34 PM | uk.finance.yahoo.comSee More First Tracks Biotherapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like First Tracks Biotherapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on First Tracks Biotherapeutics and other key companies, straight to your email. Email Address About First Tracks BiotherapeuticsFirst Tracks Biotherapeutics (NASDAQ:TRAX) is a clinical stage biotechnology company advancing antibody therapies which modulate immune pathways implicated in autoimmune and inflammatory diseases. Its pipeline includes ANB033 and ANB101. First Tracks Biotherapeutics is based in SAN DIEGO.View First Tracks Biotherapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin PressureASML Can’t Keep Up With AI Demand—Why That's a Good ThingCiti Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenBig Banks Report Strong Earnings—So Why Are Shares Falling? Upcoming Earnings Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
